Browse by Changes
Summary of Changes – 1 April 2024
Page last updated: 1 April 2024
Previous versions of the Summary of Changes are available in PDF in the Publications Archive.
- Prescriber bag
- Additions
- Deletions
- Alterations
- Supply Only
- Advance Notices
- Palliative Care
- Highly Specialised Drugs Program (Private Hospital)
- Highly Specialised Drugs Program (Public Hospital)
- Highly Specialised Drugs Program (Community Access)
- Growth Hormone Program
- Repatriation Pharmaceutical Benefits
- Efficient Funding of Chemotherapy (Private Hospital)
- Efficient Funding of Chemotherapy (Public Hospital)
- Related Pharmaceutical Benefits for Public Hospital use
Prescriber Bag
Advance Notices
1 May 2024
Deletion – Brand
13625D | GlucaGen Hypokit (Germany), DZ – GLUCAGON HYDROCHLORIDE, glucagon hydrochloride 1 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack |
3485K | Cilicaine, AF – PROCAINE BENZYLPENICILLIN, procaine benzylpenicillin 1.5 g/3.4 mL injection, 5 x 3.4 mL syringes |
1 July 2024
Deletion – Brand
12108G | Asmol CFC-Free with dose counter, AF – SALBUTAMOL, salbutamol 100 microgram/actuation inhalation, 200 actuations |
12108G | Zempreon CFC-Free with dose counter, AL – SALBUTAMOL, salbutamol 100 microgram/actuation inhalation, 200 actuations |
General Pharmaceutical Benefits
Additions
Addition – Item
14092Q | EMPAGLIFLOZIN, empagliflozin 10 mg tablet, 30 (Jardiance) |
13127X | ETHOSUXIMIDE, ethosuximide 250 mg capsule, 56 (Ethosuximide Essential Generics (UK)) |
14087K | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) |
14101E | INCLISIRAN, inclisiran 284 mg/1.5 mL injection, 1.5 mL syringe (Leqvio) |
14091P | METHOTREXATE, methotrexate 7.5 mg/0.15 mL injection, 0.15 mL syringe (Trexject) |
14089M | METHOTREXATE, methotrexate 10 mg/0.2 mL injection, 0.2 mL syringe (Trexject) |
14102F | METHOTREXATE, methotrexate 15 mg/0.3 mL injection, 0.3 mL syringe (Trexject) |
14097Y | METHOTREXATE, methotrexate 20 mg/0.4 mL injection, 0.4 mL syringe (Trexject) |
14103G | METHOTREXATE, methotrexate 25 mg/0.5 mL injection, 0.5 mL syringe (Trexject) |
14088L | NIRAPARIB, niraparib 100 mg capsule, 56 (Zejula) |
14094T | NIRAPARIB, niraparib 100 mg capsule, 56 (Zejula) |
14098B | NIRAPARIB, niraparib 100 mg capsule, 84 (Zejula) |
14104H | NIRAPARIB, niraparib 100 mg capsule, 84 (Zejula) |
14093R | TERIPARATIDE, teriparatide 250 microgram/mL injection, 2.4 mL pen device (Terrosa) |
Addition – Brand
8200N | Azithromycin Viatris, AL – AZITHROMYCIN, azithromycin 500 mg tablet, 2 |
8336R | Azithromycin Viatris, AL – AZITHROMYCIN, azithromycin 500 mg tablet, 2 |
2460L | Cefaclor SUN, RA – CEFACLOR, cefaclor 125 mg/5 mL powder for oral liquid, 100 mL |
5046N | Cefaclor SUN, RA – CEFACLOR, cefaclor 125 mg/5 mL powder for oral liquid, 100 mL |
2461M | Cefaclor SUN, RA – CEFACLOR, cefaclor 250 mg/5 mL powder for oral liquid, 75 mL |
5047P | Cefaclor SUN, RA – CEFACLOR, cefaclor 250 mg/5 mL powder for oral liquid, 75 mL |
1299J | Fenac EC, AL – DICLOFENAC, diclofenac sodium 25 mg enteric tablet, 50 |
5076E | Fenac EC, AL – DICLOFENAC, diclofenac sodium 25 mg enteric tablet, 50 |
1300K | Fenac EC, AL – DICLOFENAC, diclofenac sodium 50 mg enteric tablet, 50 |
5077F | Fenac EC, AL – DICLOFENAC, diclofenac sodium 50 mg enteric tablet, 50 |
8431R | Salflumix Easyhaler 250/50, OX – FLUTICASONE PROPIONATE + SALMETEROL, fluticasone propionate 250 microgram/actuation + salmeterol 50 microgram/actuation powder for inhalation, 60 actuations |
8432T | Salflumix Easyhaler 500/50, OX – FLUTICASONE PROPIONATE + SALMETEROL, fluticasone propionate 500 microgram/actuation + salmeterol 50 microgram/actuation powder for inhalation, 60 actuations |
11107N | FOSAPREPITANT MEDSURGE, DZ – FOSAPREPITANT, fosaprepitant 150 mg injection, 1 vial |
11753N | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
11762C | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
11769K | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
11775R | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
11780B | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
11781C | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
11784F | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
11787J | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
11880G | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
5443L | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
9111M | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
9113P | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
9115R | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
9123E | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
9172R | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
9174W | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
9176Y | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
9178C | Imatinib Sandoz, SZ – IMATINIB, imatinib 100 mg tablet, 60 |
11752M | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
11758W | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
11765F | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
11778X | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
11785G | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
11786H | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
11788K | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
11789L | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
11878E | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
5444M | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
9112N | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
9114Q | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
9116T | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
9124F | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
9173T | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
9175X | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
9177B | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
9179D | Imatinib Sandoz, SZ – IMATINIB, imatinib 400 mg tablet, 30 |
13435D | Blooms Irbesartan, BG – IRBESARTAN, irbesartan 75 mg tablet, 30 |
8246B | Blooms Irbesartan, BG – IRBESARTAN, irbesartan 75 mg tablet, 30 |
13380F | Blooms Irbesartan, BG – IRBESARTAN, irbesartan 150 mg tablet, 30 |
8247C | Blooms Irbesartan, BG – IRBESARTAN, irbesartan 150 mg tablet, 30 |
13564X | Blooms Irbesartan, BG – IRBESARTAN, irbesartan 300 mg tablet, 30 |
8248D | Blooms Irbesartan, BG – IRBESARTAN, irbesartan 300 mg tablet, 30 |
1629R | Hydopa, AF – METHYLDOPA, methyldopa 250 mg tablet, 100 |
14000W | ARX-MYCOPHENOLATE, XT – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
8650G | ARX-MYCOPHENOLATE, XT – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
8186W | APO-OLANZAPINE, TX – OLANZAPINE, olanzapine 7.5 mg tablet, 28 |
10797G | Parapane OSTEO, AF – PARACETAMOL, paracetamol 665 mg modified release tablet, 192 |
9393J | APO-Pramipexole, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 125 microgram tablet, 30 |
9394K | APO-Pramipexole, TX – PRAMIPEXOLE, pramipexole dihydrochloride monohydrate 250 microgram tablet, 100 |
8456C | APX-QUETIAPINE, TX – QUETIAPINE, quetiapine 25 mg tablet, 60 |
8458E | APX-QUETIAPINE, TX – QUETIAPINE, quetiapine 200 mg tablet, 60 |
8580N | APX-QUETIAPINE, TX – QUETIAPINE, quetiapine 300 mg tablet, 60 |
11276L | TENOFOVIR/EMTRICITABINE 300/200 ARX, XT – TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 |
Addition – Equivalence Indicator
11703Y | Zarontin, IX – ETHOSUXIMIDE, ethosuximide 250 mg capsule, 100 |
1629R | Aldomet, AS – METHYLDOPA, methyldopa 250 mg tablet, 100 |
12670W | Terrosa, FX – TERIPARATIDE, teriparatide 250 microgram/mL injection, 2.4 mL cartridge |
Addition – Note
11703Y | ETHOSUXIMIDE, ethosuximide 250 mg capsule, 100 (Zarontin) |
13783K | OLAPARIB, olaparib 100 mg tablet, 56 (Lynparza) |
13800H | OLAPARIB, olaparib 150 mg tablet, 56 (Lynparza) |
11416W | PEGINTERFERON ALFA-2A, peginterferon alfa-2a 135 microgram/0.5 mL injection, 4 x 0.5 mL syringes (Pegasys) |
11037X | PEGINTERFERON ALFA-2A, peginterferon alfa-2a 180 microgram/0.5 mL injection, 4 x 0.5 mL syringes (Pegasys) |
12670W | TERIPARATIDE, teriparatide 250 microgram/mL injection, 2.4 mL cartridge (Terrosa) |
Deletions
Deletion – Item
5263B | METHYLPREDNISOLONE, methylprednisolone 40 mg injection, 5 vials (Methylpred) |
8490W | MORPHINE, morphine sulfate pentahydrate 20 mg modified release granules, 28 sachets (MS Contin Suspension 20 mg) |
8146R | MORPHINE, morphine sulfate pentahydrate 30 mg modified release granules, 28 sachets (MS Contin Suspension 30 mg) |
8305D | MORPHINE, morphine sulfate pentahydrate 60 mg modified release granules, 28 sachets (MS Contin Suspension 60 mg) |
8306E | MORPHINE, morphine sulfate pentahydrate 100 mg modified release granules, 28 sachets (MS Contin Suspension 100 mg) |
12053J | MORPHINE, morphine sulfate pentahydrate 200 mg modified release granules, 28 sachets (MS Contin Suspension 200 mg) |
8454Y | MORPHINE, morphine sulfate pentahydrate 200 mg modified release granules, 28 sachets (MS Contin Suspension 200 mg) |
2746M | TROPISETRON, tropisetron 5 mg/5 mL injection, 5 mL ampoule (Tropisetron-AFT) |
Deletion – Brand
1299J | Fenac 25, AF – DICLOFENAC, diclofenac sodium 25 mg enteric tablet, 50 |
5076E | Fenac 25, AF – DICLOFENAC, diclofenac sodium 25 mg enteric tablet, 50 |
1300K | Fenac, AF – DICLOFENAC, diclofenac sodium 50 mg enteric tablet, 50 |
5077F | Fenac, AF – DICLOFENAC, diclofenac sodium 50 mg enteric tablet, 50 |
10780J | Eryc, YN – ERYTHROMYCIN, erythromycin 250 mg enteric capsule, 25 |
1404X | Eryc, YN – ERYTHROMYCIN, erythromycin 250 mg enteric capsule, 25 |
3325B | Eryc, YN – ERYTHROMYCIN, erythromycin 250 mg enteric capsule, 25 |
13848W | Aylide 1, AF – GLIMEPIRIDE, glimepiride 1 mg tablet, 30 |
8450R | Aylide 1, AF – GLIMEPIRIDE, glimepiride 1 mg tablet, 30 |
13870B | Aylide 2, AF – GLIMEPIRIDE, glimepiride 2 mg tablet, 30 |
8451T | Aylide 2, AF – GLIMEPIRIDE, glimepiride 2 mg tablet, 30 |
14020X | Aylide 3, AF – GLIMEPIRIDE, glimepiride 3 mg tablet, 30 |
8533D | Aylide 3, AF – GLIMEPIRIDE, glimepiride 3 mg tablet, 30 |
14055R | Aylide 4, AF – GLIMEPIRIDE, glimepiride 4 mg tablet, 30 |
8452W | Aylide 4, AF – GLIMEPIRIDE, glimepiride 4 mg tablet, 30 |
10526B | Ardix Lurasidone, RX – LURASIDONE, lurasidone hydrochloride 40 mg tablet, 30 |
10529E | Ardix Lurasidone, RX – LURASIDONE, lurasidone hydrochloride 80 mg tablet, 30 |
2335X | Pregabalin GH, GQ – PREGABALIN, pregabalin 75 mg capsule, 56 |
2355Y | Pregabalin GH, GQ – PREGABALIN, pregabalin 150 mg capsule, 56 |
2893G | Stemzine, AV – PROCHLORPERAZINE, prochlorperazine maleate 5 mg tablet, 25 |
5205Y | Stemzine, AV – PROCHLORPERAZINE, prochlorperazine maleate 5 mg tablet, 25 |
11877D | Risperidone generichealth, GQ – RISPERIDONE, risperidone 1 mg tablet, 60 |
11879F | Risperidone generichealth, GQ – RISPERIDONE, risperidone 1 mg tablet, 60 |
3169T | Risperidone generichealth, GQ – RISPERIDONE, risperidone 1 mg tablet, 60 |
8789N | Risperidone generichealth, GQ – RISPERIDONE, risperidone 1 mg tablet, 60 |
3170W | Risperidone generichealth, GQ – RISPERIDONE, risperidone 2 mg tablet, 60 |
9079W | Risperidone generichealth, GQ – RISPERIDONE, risperidone 2 mg tablet, 60 |
3171X | Risperidone generichealth, GQ – RISPERIDONE, risperidone 3 mg tablet, 60 |
10198R | Vfend, PF – VORICONAZOLE, voriconazole 200 mg tablet, 56 |
9364W | Vfend, PF – VORICONAZOLE, voriconazole 200 mg tablet, 56 |
Deletion – Equivalence Indicator
10780J | Mayne Pharma Erythromycin, YT – ERYTHROMYCIN, erythromycin 250 mg enteric capsule, 25 |
1404X | Mayne Pharma Erythromycin, YT – ERYTHROMYCIN, erythromycin 250 mg enteric capsule, 25 |
3325B | Mayne Pharma Erythromycin, YT – ERYTHROMYCIN, erythromycin 250 mg enteric capsule, 25 |
Deletion – Note
13094E | GILTERITINIB, gilteritinib 40 mg tablet, 84 (Xospata) |
Deletion – Restriction
13094E | GILTERITINIB, gilteritinib 40 mg tablet, 84 (Xospata) |
Alterations
Alteration – Note
12613W | ALIROCUMAB, alirocumab 75 mg/mL injection, 2 x 1 mL pen devices (Praluent) |
12604J | ALIROCUMAB, alirocumab 150 mg/mL injection, 2 x 1 mL pen devices (Praluent) |
12005W | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia) |
12040Q | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia) |
12063X | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia) |
12013G | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia) |
12027B | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia) |
12028C | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia) |
11484K | EVOLOCUMAB, evolocumab 140 mg/mL injection, 1 mL pen device (Repatha) |
11485L | EVOLOCUMAB, evolocumab 420 mg/3.5 mL injection, 3.5 mL cartridge (Repatha) |
11516D | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi) |
11521J | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi) |
11538G | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi) |
11560K | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi) |
12628P | LACOSAMIDE, lacosamide 10 mg/mL oral liquid, 200 mL (Vimpat) |
14013M | LACOSAMIDE, lacosamide 10 mg/mL oral liquid, 200 mL (Vimpat) |
12626M | LACOSAMIDE, lacosamide 50 mg tablet, 14 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
14049K | LACOSAMIDE, lacosamide 50 mg tablet, 14 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
12634Y | LACOSAMIDE, lacosamide 100 mg tablet, 56 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
13839J | LACOSAMIDE, lacosamide 100 mg tablet, 56 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
12627N | LACOSAMIDE, lacosamide 150 mg tablet, 56 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
13838H | LACOSAMIDE, lacosamide 150 mg tablet, 56 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
12658F | LACOSAMIDE, lacosamide 200 mg tablet, 56 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
13949E | LACOSAMIDE, lacosamide 200 mg tablet, 56 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
11739W | METHYLPREDNISOLONE, methylprednisolone 40 mg injection [1 chamber] (&) inert substance diluent [1 mL chamber], 1 dual chamber vial (Solu-Medrol) |
13736Y | METHYLPREDNISOLONE, methylprednisolone (as sodium succinate) 40 mg powder for injection, 1 vial (Solu-Medrone) |
13089X | NIRAPARIB, niraparib 100 mg capsule, 56 (Zejula) |
13092C | NIRAPARIB, niraparib 100 mg capsule, 84 (Zejula) |
12297F | SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx) |
12307R | SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx) |
12321L | SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx) |
13343G | UPADACITINIB, upadacitinib 15 mg modified release tablet, 28 (Rinvoq) |
13350P | UPADACITINIB, upadacitinib 15 mg modified release tablet, 28 (Rinvoq) |
Alteration – Restriction
13792X | ACALABRUTINIB, acalabrutinib 100 mg tablet, 56 (CALQUENCE) |
13810W | ACALABRUTINIB, acalabrutinib 100 mg tablet, 56 (CALQUENCE) |
12607M | ALIROCUMAB, alirocumab 75 mg/mL injection, 2 x 1 mL pen devices (Praluent) |
12613W | ALIROCUMAB, alirocumab 75 mg/mL injection, 2 x 1 mL pen devices (Praluent) |
12604J | ALIROCUMAB, alirocumab 150 mg/mL injection, 2 x 1 mL pen devices (Praluent) |
12608N | ALIROCUMAB, alirocumab 150 mg/mL injection, 2 x 1 mL pen devices (Praluent) |
12063X | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes (Cimzia) |
12027B | CERTOLIZUMAB PEGOL, certolizumab pegol 200 mg/mL injection, 2 x 1 mL pen devices (Cimzia) |
11484K | EVOLOCUMAB, evolocumab 140 mg/mL injection, 1 mL pen device (Repatha) |
11985T | EVOLOCUMAB, evolocumab 140 mg/mL injection, 1 mL pen device (Repatha) |
11485L | EVOLOCUMAB, evolocumab 420 mg/3.5 mL injection, 3.5 mL cartridge (Repatha) |
11986W | EVOLOCUMAB, evolocumab 420 mg/3.5 mL injection, 3.5 mL cartridge (Repatha) |
8431R | FLUTICASONE PROPIONATE + SALMETEROL, fluticasone propionate 250 microgram/actuation + salmeterol 50 microgram/actuation powder for inhalation, 60 actuations (Fluticasone Salmeterol Ciphaler 250/50, PAVTIDE ACCUHALER 250/50, Salflumix Easyhaler 250/50, Seretide Accuhaler 250/50) |
8432T | FLUTICASONE PROPIONATE + SALMETEROL, fluticasone propionate 500 microgram/actuation + salmeterol 50 microgram/actuation powder for inhalation, 60 actuations (Fluticasone Salmeterol Ciphaler 500/50, PAVTIDE ACCUHALER 500/50, Salflumix Easyhaler 500/50, Seretide Accuhaler 500/50) |
11516D | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi) |
11521J | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi) |
11538G | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL pen device (Simponi) |
11560K | GOLIMUMAB, golimumab 50 mg/0.5 mL injection, 0.5 mL syringe (Simponi) |
12628P | LACOSAMIDE, lacosamide 10 mg/mL oral liquid, 200 mL (Vimpat) |
14013M | LACOSAMIDE, lacosamide 10 mg/mL oral liquid, 200 mL (Vimpat) |
12626M | LACOSAMIDE, lacosamide 50 mg tablet, 14 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
14049K | LACOSAMIDE, lacosamide 50 mg tablet, 14 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
12634Y | LACOSAMIDE, lacosamide 100 mg tablet, 56 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
13839J | LACOSAMIDE, lacosamide 100 mg tablet, 56 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
12627N | LACOSAMIDE, lacosamide 150 mg tablet, 56 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
13838H | LACOSAMIDE, lacosamide 150 mg tablet, 56 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
12658F | LACOSAMIDE, lacosamide 200 mg tablet, 56 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
13949E | LACOSAMIDE, lacosamide 200 mg tablet, 56 (Lacosam, Lacosamide ARX, Lacosamide Lupin, Lacosamide Sandoz, Vimcosa, Vimpat) |
13079J | NIRAPARIB, niraparib 100 mg capsule, 84 (Zejula) |
13089X | NIRAPARIB, niraparib 100 mg capsule, 56 (Zejula) |
13092C | NIRAPARIB, niraparib 100 mg capsule, 84 (Zejula) |
13112D | NIRAPARIB, niraparib 100 mg capsule, 56 (Zejula) |
13783K | OLAPARIB, olaparib 100 mg tablet, 56 (Lynparza) |
13800H | OLAPARIB, olaparib 150 mg tablet, 56 (Lynparza) |
8233H | ONDANSETRON, ondansetron 4 mg/5 mL oral liquid, 50 mL (Zofran syrup 50 mL) |
1594X | ONDANSETRON, ondansetron 4 mg tablet, 10 (APO-Ondansetron, APX-Ondansetron, Ondansetron Mylan Tablets, Ondansetron SZ, Ondansetron-DRLA, Zofran, Zotren 4) |
5472B | ONDANSETRON, ondansetron 4 mg orally disintegrating tablet, 10 (APX-Ondansetron ODT, Ondansetron Mylan ODT, Ondansetron ODT Lupin, Ondansetron ODT-DRLA, Ondansetron SZ ODT, Zotren ODT) |
1595Y | ONDANSETRON, ondansetron 8 mg tablet, 10 (APO-Ondansetron, APX-Ondansetron, Ondansetron Mylan Tablets, Ondansetron SZ, Ondansetron-DRLA, Zofran, Zotren 8) |
5473C | ONDANSETRON, ondansetron 8 mg orally disintegrating tablet, 10 (APX-Ondansetron ODT, Ondansetron Mylan ODT, Ondansetron ODT Lupin, Ondansetron ODT-DRLA, Ondansetron SZ ODT, Zotren ODT) |
8412R | ONDANSETRON, ondansetron 4 mg wafer, 10 (Zofran Zydis) |
8413T | ONDANSETRON, ondansetron 8 mg wafer, 10 (Zofran Zydis) |
12321L | SECUKINUMAB, secukinumab 150 mg/mL injection, 1 mL pen device (Cosentyx) |
13343G | UPADACITINIB, upadacitinib 15 mg modified release tablet, 28 (Rinvoq) |
13350P | UPADACITINIB, upadacitinib 15 mg modified release tablet, 28 (Rinvoq) |
Alteration – Manufacturer Code
From | To | ||
13592J | Atacand – CANDESARTAN, candesartan cilexetil 4 mg tablet, 30 | AP | LM |
8295N | Atacand – CANDESARTAN, candesartan cilexetil 4 mg tablet, 30 | AP | LM |
13436E | Atacand – CANDESARTAN, candesartan cilexetil 8 mg tablet, 30 | AP | LM |
8296P | Atacand – CANDESARTAN, candesartan cilexetil 8 mg tablet, 30 | AP | LM |
13565Y | Atacand – CANDESARTAN, candesartan cilexetil 16 mg tablet, 30 | AP | LM |
8297Q | Atacand – CANDESARTAN, candesartan cilexetil 16 mg tablet, 30 | AP | LM |
13438G | Atacand – CANDESARTAN, candesartan cilexetil 32 mg tablet, 30 | AP | LM |
8889W | Atacand – CANDESARTAN, candesartan cilexetil 32 mg tablet, 30 | AP | LM |
13391T | Atacand Plus 16/12.5 – CANDESARTAN + HYDROCHLOROTHIAZIDE, candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg tablet, 30 | AP | LM |
8504N | Atacand Plus 16/12.5 – CANDESARTAN + HYDROCHLOROTHIAZIDE, candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg tablet, 30 | AP | LM |
13452B | Atacand Plus 32/12.5 – CANDESARTAN + HYDROCHLOROTHIAZIDE, candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg tablet, 30 | AP | LM |
9314F | Atacand Plus 32/12.5 – CANDESARTAN + HYDROCHLOROTHIAZIDE, candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg tablet, 30 | AP | LM |
13392W | Atacand Plus 32/25 – CANDESARTAN + HYDROCHLOROTHIAZIDE, candesartan cilexetil 32 mg + hydrochlorothiazide 25 mg tablet, 30 | AP | LM |
9315G | Atacand Plus 32/25 – CANDESARTAN + HYDROCHLOROTHIAZIDE, candesartan cilexetil 32 mg + hydrochlorothiazide 25 mg tablet, 30 | AP | LM |
2422L | Carbamazepine Sandoz – CARBAMAZEPINE, carbamazepine 100 mg tablet, 100 | SZ | NM |
5039F | Carbamazepine Sandoz – CARBAMAZEPINE, carbamazepine 100 mg tablet, 100 | SZ | NM |
1706T | Carbamazepine Sandoz – CARBAMAZEPINE, carbamazepine 200 mg tablet, 100 | SZ | NM |
1724R | Carbamazepine Sandoz – CARBAMAZEPINE, carbamazepine 200 mg tablet, 100 | SZ | NM |
13883Q | Cyclosporin Sandoz – CICLOSPORIN, ciclosporin 25 mg capsule, 30 | SZ | NM |
8658Q | Cyclosporin Sandoz – CICLOSPORIN, ciclosporin 25 mg capsule, 30 | SZ | NM |
13910D | Cyclosporin Sandoz – CICLOSPORIN, ciclosporin 50 mg capsule, 30 | SZ | NM |
8659R | Cyclosporin Sandoz – CICLOSPORIN, ciclosporin 50 mg capsule, 30 | SZ | NM |
13911E | Cyclosporin Sandoz – CICLOSPORIN, ciclosporin 100 mg capsule, 30 | SZ | NM |
8660T | Cyclosporin Sandoz – CICLOSPORIN, ciclosporin 100 mg capsule, 30 | SZ | NM |
3138E | Clindamycin LU – CLINDAMYCIN, clindamycin 150 mg capsule, 24 | LV | XT |
5057E | Clindamycin LU – CLINDAMYCIN, clindamycin 150 mg capsule, 24 | LV | XT |
13587D | Fenocol – FENOFIBRATE, fenofibrate 145 mg tablet, 30 | YC | XT |
9023X | Fenocol – FENOFIBRATE, fenofibrate 145 mg tablet, 30 | YC | XT |
10104T | Ferinject – FERRIC CARBOXYMALTOSE, iron (as ferric carboxymaltose) 500 mg/10 mL injection, 10 mL vial | VL | CS |
11702X | Ferinject – FERRIC CARBOXYMALTOSE, iron (as ferric carboxymaltose) 1 g/20 mL injection, 20 mL vial | VL | CS |
1824B | FEMIN – MEFENAMIC ACID, mefenamic acid 250 mg capsule, 50 | LI | XT |
1746X | Febridol – PARACETAMOL, paracetamol 500 mg tablet, 100 | EA | XT |
5196L | Febridol – PARACETAMOL, paracetamol 500 mg tablet, 100 | EA | XT |
5224Y | Febridol – PARACETAMOL, paracetamol 500 mg tablet, 100 | EA | XT |
8784H | Febridol – PARACETAMOL, paracetamol 500 mg tablet, 100 | EA | XT |
12764T | Qinlock – RIPRETINIB, ripretinib 50 mg tablet, 90 | TS | ZB |
9009E | Velabine – VINORELBINE, vinorelbine 20 mg capsule, 1 | LI | XT |
9010F | Velabine – VINORELBINE, vinorelbine 30 mg capsule, 1 | LI | XT |
Alteration – Maximum Quantity
From | To | ||
13300B | CHORIOGONADOTROPIN ALFA, choriogonadotropin alfa 250 microgram/0.5 mL injection, 0.5 mL pen device (Ovidrel) | 1 | 4 |
Supply Only
When a product is deleted from the Schedule it may be available under Supply Only rules. Supply Only items/brands are available on the Schedule for dispensing but not for prescribing, usually for a period of up to 12 months from when it is deleted.
Substitution of Supply Only items/brands with products flagged as “equivalent for substitution” still apply as specified in the Schedule at the time the script was written.
Further information on Supply Only arrangements is available at https://www.pbs.gov.au/browse/medicine-listing/supply-only
Supply Only Commencing 1 April 2023
12704P | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |
8485N | ESTRADIOL, estradiol 25 microgram/24 hours patch, 4 (Climara 25) |
8125P | ESTRADIOL, estradiol 50 microgram/24 hours patch, 4 (Climara 50) |
8486P | ESTRADIOL, estradiol 75 microgram/24 hours patch, 4 (Climara 75) |
8126Q | ESTRADIOL, estradiol 100 microgram/24 hours patch, 4 (Climara 100) |
12645M | OBETICHOLIC ACID, obeticholic acid 5 mg tablet, 30 (Ocaliva) |
12631T | OBETICHOLIC ACID, obeticholic acid 10 mg tablet, 30 (Ocaliva) |
2167C | RETINOL PALMITATE + PARAFFIN, retinol palmitate 0.0138% + paraffin eye ointment, 5 g (VitA-POS) |
2202X | RETINOL PALMITATE + PARAFFIN, retinol palmitate 0.0138% + paraffin eye ointment, 5 g (VitA-POS) |
2222Y | RETINOL PALMITATE + PARAFFIN, retinol palmitate 0.0138% + paraffin eye ointment, 5 g (VitA-POS) |
Advance Notices
1 May 2024
Deletion – Brand
5484P | GA express 15, VF – AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT LYSINE AND LOW IN TRYPTOPHAN, amino acid formula with vitamins and minerals without lysine and low in tryptophan powder for oral liquid, 30 x 25 g sachets |
13532F | Norvapine, ED – AMLODIPINE, amlodipine 5 mg tablet, 30 |
13562T | Norvapine, ED – AMLODIPINE, amlodipine 10 mg tablet, 30 |
2751T | Norvapine, ED – AMLODIPINE, amlodipine 5 mg tablet, 30 |
2752W | Norvapine, ED – AMLODIPINE, amlodipine 10 mg tablet, 30 |
13179P | Amoxicillin and clavulanate potassium tablets, USP 875 mg/125 mg (Aurobindo – Pro Pharmaceuticals), QY – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 20 |
13179P | Amoxicillin and clavulanate potassium tablets, USP 875 mg/125 mg (Micro Labs), QZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 20 |
13190F | Amoxicillin and clavulanate potassium tablets, USP 875 mg/125 mg (Aurobindo – Pro Pharmaceuticals), QY – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 20 |
13190F | Amoxicillin and clavulanate potassium tablets, USP 875 mg/125 mg (Micro Labs), QZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 20 |
13194K | Amoxicillin and clavulanate potassium tablets, USP 875 mg/125 mg (Aurobindo – Pro Pharmaceuticals), QY – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 20 |
13194K | Amoxicillin and clavulanate potassium tablets, USP 875 mg/125 mg (Micro Labs), QZ – AMOXICILLIN + CLAVULANIC ACID, amoxicillin 875 mg + clavulanic acid 125 mg tablet, 20 |
8361C | Capecitabine-DRLA, RZ – CAPECITABINE, capecitabine 150 mg tablet, 60 |
5502N | Poly Gel, AQ – CARBOMER-974P, carbomer-974P 0.3% eye gel, 30 x 500 mg ampoules |
8514D | Poly Gel, AQ – CARBOMER-974P, carbomer-974P 0.3% eye gel, 30 x 500 mg ampoules |
13278W | Keforal, QY – CEFALEXIN, cefalexin 250 mg/5 mL powder for oral liquid, 100 mL |
13285F | Keforal, QY – CEFALEXIN, cefalexin 250 mg/5 mL powder for oral liquid, 100 mL |
11191B | Zinnat, AS – CEFUROXIME, cefuroxime 125 mg/5 mL powder for oral liquid, 100 mL |
11192C | Zinnat, AS – CEFUROXIME, cefuroxime 125 mg/5 mL powder for oral liquid, 100 mL |
5521N | Bion Tears, AQ – DEXTRAN-70 + HYPROMELLOSE, dextran-70 0.1% + hypromellose 0.3% eye drops, 28 x 0.4 mL ampoules |
8299T | Bion Tears, AQ – DEXTRAN-70 + HYPROMELLOSE, dextran-70 0.1% + hypromellose 0.3% eye drops, 28 x 0.4 mL ampoules |
1438Q | Flarex, NV – FLUOROMETHOLONE ACETATE, fluorometholone acetate 0.1% eye drops, 5 mL |
5533F | Flarex, NV – FLUOROMETHOLONE ACETATE, fluorometholone acetate 0.1% eye drops, 5 mL |
13612K | GlucaGen Hypokit (Germany), DZ – GLUCAGON HYDROCHLORIDE, glucagon hydrochloride 1 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack |
13614M | GlucaGen Hypokit (Germany), DZ – GLUCAGON HYDROCHLORIDE, glucagon hydrochloride 1 mg injection [1 vial] (&) inert substance diluent [1 mL syringe], 1 pack |
13279X | Minoxidil 10 mg (Roma Pharmaceuticals), OJ – MINOXIDIL, minoxidil 10 mg tablet, 60 |
1794K | Cilicaine, AF – PROCAINE BENZYLPENICILLIN, procaine benzylpenicillin 1.5 g/3.4 mL injection, 5 x 3.4 mL syringes |
3371K | Cilicaine, AF – PROCAINE BENZYLPENICILLIN, procaine benzylpenicillin 1.5 g/3.4 mL injection, 5 x 3.4 mL syringes |
3172Y | Risperidone generichealth, GQ – RISPERIDONE, risperidone 4 mg tablet, 60 |
11296M | Tenofovir Disoproxil Emtricitabine Mylan 300/200, AF – TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 |
13913G | Topamax, JC – TOPIRAMATE, topiramate 50 mg tablet, 60 |
13969F | Topamax, JC – TOPIRAMATE, topiramate 25 mg tablet, 60 |
14008G | Topamax, JC – TOPIRAMATE, topiramate 100 mg tablet, 60 |
14009H | Topamax, JC – TOPIRAMATE, topiramate 200 mg tablet, 60 |
8163P | Topamax, JC – TOPIRAMATE, topiramate 25 mg tablet, 60 |
8164Q | Topamax, JC – TOPIRAMATE, topiramate 50 mg tablet, 60 |
8165R | Topamax, JC – TOPIRAMATE, topiramate 100 mg tablet, 60 |
8166T | Topamax, JC – TOPIRAMATE, topiramate 200 mg tablet, 60 |
10785P | Trimethoprim Mylan, AL – TRIMETHOPRIM, trimethoprim 300 mg tablet, 7 |
2666H | Trimethoprim Mylan, AL – TRIMETHOPRIM, trimethoprim 300 mg tablet, 7 |
2922T | Trimethoprim Mylan, AL – TRIMETHOPRIM, trimethoprim 300 mg tablet, 7 |
1 June 2024
Deletion – Brand
12114N | Ceftriaxone Alphapharm, AF – CEFTRIAXONE, ceftriaxone 1 g injection, 10 vials |
1788D | Ceftriaxone Alphapharm, AF – CEFTRIAXONE, ceftriaxone 1 g injection, 5 vials |
1357K | Dosulepin Mylan, AL – DOSULEPIN (DOTHIEPIN), dosulepin (dothiepin) hydrochloride 25 mg capsule, 50 |
13369P | Enalapril generichealth, GQ – ENALAPRIL, enalapril maleate 5 mg tablet, 30 |
13465Q | Enalapril generichealth, GQ – ENALAPRIL, enalapril maleate 10 mg tablet, 30 |
1368B | Enalapril generichealth, GQ – ENALAPRIL, enalapril maleate 10 mg tablet, 30 |
1370D | Enalapril generichealth, GQ – ENALAPRIL, enalapril maleate 5 mg tablet, 30 |
1 July 2024
Deletion – Brand
12117R | Calquence, AP – ACALABRUTINIB, acalabrutinib 100 mg capsule, 56 |
12826C | Calquence, AP – ACALABRUTINIB, acalabrutinib 100 mg capsule, 56 |
8717T | Aripic Aripiprazole, LR – ARIPIPRAZOLE, aripiprazole 10 mg tablet, 30 |
13468W | Atorvastatin GH, GQ – ATORVASTATIN, atorvastatin 40 mg tablet, 30 |
13495G | Atorvastatin GH, GQ – ATORVASTATIN, atorvastatin 10 mg tablet, 30 |
8213G | Atorvastatin GH, GQ – ATORVASTATIN, atorvastatin 10 mg tablet, 30 |
8215J | Atorvastatin GH, GQ – ATORVASTATIN, atorvastatin 40 mg tablet, 30 |
11169W | Ceftriaxone Alphapharm, AF – CEFTRIAXONE, ceftriaxone 2 g injection, 5 vials |
12112L | Ceftriaxone Alphapharm, AF – CEFTRIAXONE, ceftriaxone 2 g injection, 10 vials |
12109H | Asmol CFC-Free with dose counter, AF – SALBUTAMOL, salbutamol 100 microgram/actuation inhalation, 200 actuations |
12109H | Zempreon CFC-Free with dose counter, AL – SALBUTAMOL, salbutamol 100 microgram/actuation inhalation, 200 actuations |
1 August 2024
Deletion – Brand
13884R | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 250 mg capsule, 100 |
14000W | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
8649F | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 250 mg capsule, 100 |
8650G | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
Palliative Care
Additions
Addition – Brand
10796F | Parapane OSTEO, AF – PARACETAMOL, paracetamol 665 mg modified release tablet, 192 |
Deletions
Deletion – Item
12528J | MORPHINE, morphine sulfate pentahydrate 20 mg modified release granules, 28 sachets (MS Contin Suspension 20 mg) |
12488G | MORPHINE, morphine sulfate pentahydrate 30 mg modified release granules, 28 sachets (MS Contin Suspension 30 mg) |
12536T | MORPHINE, morphine sulfate pentahydrate 60 mg modified release granules, 28 sachets (MS Contin Suspension 60 mg) |
12495P | MORPHINE, morphine sulfate pentahydrate 100 mg modified release granules, 28 sachets (MS Contin Suspension 100 mg) |
12505E | MORPHINE, morphine sulfate pentahydrate 200 mg modified release granules, 28 sachets (MS Contin Suspension 200 mg) |
Highly Specialised Drugs Program (Private Hospital)
Additions
Addition – Item
14090N | NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza) |
14096X | NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza) |
Addition – Brand
6209T | ARX-MYCOPHENOLATE, XT – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
13814C | Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 1 mg capsule, 21 |
13811X | Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 2 mg capsule, 21 |
Addition – Note
6439X | PEGINTERFERON ALFA-2A, peginterferon alfa-2a 135 microgram/0.5 mL injection, 4 x 0.5 mL syringes (Pegasys) |
6449K | PEGINTERFERON ALFA-2A, peginterferon alfa-2a 180 microgram/0.5 mL injection, 4 x 0.5 mL syringes (Pegasys) |
Deletions
Deletion – Note
11031N | RIOCIGUAT, riociguat 500 microgram tablet, 42 (Adempas) |
11028K | RIOCIGUAT, riociguat 1 mg tablet, 42 (Adempas) |
11046J | RIOCIGUAT, riociguat 1.5 mg tablet, 42 (Adempas) |
11045H | RIOCIGUAT, riociguat 2 mg tablet, 42 (Adempas) |
11052Q | RIOCIGUAT, riociguat 2.5 mg tablet, 42 (Adempas) |
13105R | SELINEXOR, selinexor 20 mg tablet, 32 (Xpovio) |
Deletion – Restriction
13105R | SELINEXOR, selinexor 20 mg tablet, 32 (Xpovio) |
Alterations
Alteration – Note
11476B | NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza) |
Alteration – Restriction
11476B | NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza) |
12176W | NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza) |
12609P | RISDIPLAM, risdiplam 750 microgram/mL powder for oral liquid, 80 mL (Evrysdi) |
Alteration – Manufacturer Code
From | To | ||
12201E | PULMORIS – AMBRISENTAN, ambrisentan 5 mg tablet, 30 | YC | XT |
9648T | PULMORIS – AMBRISENTAN, ambrisentan 5 mg tablet, 30 | YC | XT |
12180C | PULMORIS – AMBRISENTAN, ambrisentan 10 mg tablet, 30 | YC | XT |
9649W | PULMORIS – AMBRISENTAN, ambrisentan 10 mg tablet, 30 | YC | XT |
6352H | Cyclosporin Sandoz – CICLOSPORIN, ciclosporin 25 mg capsule, 30 | SZ | NM |
6353J | Cyclosporin Sandoz – CICLOSPORIN, ciclosporin 50 mg capsule, 30 | SZ | NM |
6354K | Cyclosporin Sandoz – CICLOSPORIN, ciclosporin 100 mg capsule, 30 | SZ | NM |
Advance Notices
1 June 2024
Deletion – Brand
12201E | Ambrisentan Mylan, AF – AMBRISENTAN, ambrisentan 5 mg tablet, 30 |
9648T | Ambrisentan Mylan, AF – AMBRISENTAN, ambrisentan 5 mg tablet, 30 |
1 August 2024
Deletion – Brand
6208R | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 250 mg capsule, 100 |
6209T | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
Highly Specialised Drugs Program (Public Hospital)
Additions
Addition – Item
14095W | NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza) |
14099C | NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza) |
Addition – Brand
9502D | ARX-MYCOPHENOLATE, XT – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
13803L | Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 1 mg capsule, 21 |
13788Q | Pomalidomide Sandoz, SZ – POMALIDOMIDE, pomalidomide 2 mg capsule, 21 |
Addition – Note
9515T | PEGINTERFERON ALFA-2A, peginterferon alfa-2a 135 microgram/0.5 mL injection, 4 x 0.5 mL syringes (Pegasys) |
9516W | PEGINTERFERON ALFA-2A, peginterferon alfa-2a 180 microgram/0.5 mL injection, 4 x 0.5 mL syringes (Pegasys) |
Deletions
Deletion – Note
11040C | RIOCIGUAT, riociguat 500 microgram tablet, 42 (Adempas) |
11054T | RIOCIGUAT, riociguat 1 mg tablet, 42 (Adempas) |
11047K | RIOCIGUAT, riociguat 1.5 mg tablet, 42 (Adempas) |
11038Y | RIOCIGUAT, riociguat 2 mg tablet, 42 (Adempas) |
11057Y | RIOCIGUAT, riociguat 2.5 mg tablet, 42 (Adempas) |
13104Q | SELINEXOR, selinexor 20 mg tablet, 32 (Xpovio) |
Deletion – Restriction
13104Q | SELINEXOR, selinexor 20 mg tablet, 32 (Xpovio) |
Alterations
Alteration – Note
11378W | NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza) |
Alteration – Restriction
11378W | NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza) |
12177X | NUSINERSEN, nusinersen 12 mg/5 mL intrathecal injection, 5 mL vial (Spinraza) |
12606L | RISDIPLAM, risdiplam 750 microgram/mL powder for oral liquid, 80 mL (Evrysdi) |
Alteration – Manufacturer Code
From | To | ||
12212R | PULMORIS – AMBRISENTAN, ambrisentan 5 mg tablet, 30 | YC | XT |
5607D | PULMORIS – AMBRISENTAN, ambrisentan 5 mg tablet, 30 | YC | XT |
12186J | PULMORIS – AMBRISENTAN, ambrisentan 10 mg tablet, 30 | YC | XT |
5608E | PULMORIS – AMBRISENTAN, ambrisentan 10 mg tablet, 30 | YC | XT |
5634M | Cyclosporin Sandoz – CICLOSPORIN, ciclosporin 25 mg capsule, 30 | SZ | NM |
5635N | Cyclosporin Sandoz – CICLOSPORIN, ciclosporin 50 mg capsule, 30 | SZ | NM |
5636P | Cyclosporin Sandoz – CICLOSPORIN, ciclosporin 100 mg capsule, 30 | SZ | NM |
Advance Notices
1 June 2024
Deletion – Brand
12212R | Ambrisentan Mylan, AF – AMBRISENTAN, ambrisentan 5 mg tablet, 30 |
5607D | Ambrisentan Mylan, AF – AMBRISENTAN, ambrisentan 5 mg tablet, 30 |
1 August 2024
Deletion – Brand
9501C | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 250 mg capsule, 100 |
9502D | CellCept, RO – MYCOPHENOLATE, mycophenolate mofetil 500 mg tablet, 50 |
Highly Specialised Drugs Program (Community Access)
Additions
Addition – Brand
10347N | TENOFOVIR/EMTRICITABINE 300/200 ARX, XT – TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 |
Deletions
Deletion – Item
10305J | ABACAVIR + LAMIVUDINE + ZIDOVUDINE, abacavir 300 mg + lamivudine 150 mg + zidovudine 300 mg tablet, 60 (Trizivir) |
10337C | FOSAMPRENAVIR, fosamprenavir 700 mg tablet, 60 (Telzir) |
10285H | LOPINAVIR + RITONAVIR, lopinavir 100 mg + ritonavir 25 mg tablet, 60 (Kaletra) |
Advance Notices
1 May 2024
Deletion – Brand
11149T | Tenofovir Disoproxil Emtricitabine Mylan 300/200, AF – TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 |
1 June 2024
Deletion – Brand
10284G | Lamivudine 150 mg + Zidovudine 300 mg Alphapharm, AF – LAMIVUDINE + ZIDOVUDINE, lamivudine 150 mg + zidovudine 300 mg tablet, 60 |
Growth Hormone Program
Deletions
Deletion – Note
13116H | MECASERMIN, mecasermin 10 mg/mL injection, 4 mL vial (Increlex) |
Deletion – Restriction
13116H | MECASERMIN, mecasermin 10 mg/mL injection, 4 mL vial (Increlex) |
Supply Only
When a product is deleted from the Schedule it may be available under Supply Only rules. Supply Only items/brands are available on the Schedule for dispensing but not for prescribing, usually for a period of up to 12 months from when it is deleted.
Substitution of Supply Only items/brands with products flagged as “equivalent for substitution” still apply as specified in the Schedule at the time the script was written.
Further information on Supply Only arrangements is available at https://www.pbs.gov.au/browse/medicine-listing/supply-only
Supply Only Commencing 1 April 2023
9604L | SOMATROPIN, somatropin 10 mg/2 mL injection, 2 mL cartridge (NutropinAq) |
10438J | SOMATROPIN, somatropin 10 mg/2 mL injection, 2 mL cartridge (NutropinAq) |
10478L | SOMATROPIN, somatropin 10 mg/2 mL injection, 2 mL cartridge (NutropinAq) |
11650E | SOMATROPIN, somatropin 10 mg/2 mL injection, 2 mL cartridge (NutropinAq) |
Repatriation Pharmaceutical Benefits
Alterations
Alteration – Manufacturer Code
From | To | ||
10582Y | Febridol – PARACETAMOL, paracetamol 500 mg tablet, 100 | EA | XT |
10585D | Febridol – PARACETAMOL, paracetamol 500 mg tablet, 100 | EA | XT |
Efficient Funding of Chemotherapy (Private Hospital)
Additions
Addition – Note
13162R | CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
13160P | CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
Deletions
Deletion – Brand
7263G | Navelbine, FB – VINORELBINE, vinorelbine 10 mg/mL injection, 1 mL vial |
Deletion – Note
13160P | CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
Deletion – Restriction
13123Q |
AVELUMAB, avelumab 200 mg/10 mL injection, 10 mL vial (Bavencio) |
13114F |
PEMBROLIZUMAB, pembrolizumab 100 mg/4 mL injection, 4 mL vial (Keytruda) |
Alterations
Alteration – Note
13160P | CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
13162R | CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
Alteration – Restriction
13160P |
CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
13162R |
CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
13824N |
TEBENTAFUSP, tebentafusp 100 microgram/0.5 mL injection, 0.5 mL vial (Kimmtrak) |
Alteration – Manufacturer Code
From | To | ||
12508H | Abevmy – BEVACIZUMAB, bevacizumab 100 mg/4 mL injection, 4 mL vial | AF | SZ |
12508H | Abevmy – BEVACIZUMAB, bevacizumab 400 mg/16 mL injection, 16 mL vial | AF | SZ |
10383L | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
10402L | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
10589H | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
10597R | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
7264H | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
7265J | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
7266K | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
7267L | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
Alteration – Number of Repeats
From | To | ||
13793Y |
OBINUTUZUMAB, obinutuzumab 1 g/40 mL injection, 40 mL vial (Gazyva) |
5 | 7 |
Efficient Funding of Chemotherapy (Public Hospital)
Additions
Addition – Note
13161Q | CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
13169D | CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
Deletions
Deletion – Brand
4620E | Navelbine, FB – VINORELBINE, vinorelbine 10 mg/mL injection, 1 mL vial |
Deletion – Note
13169D | CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
Deletion – Restriction
13122P |
AVELUMAB, avelumab 200 mg/10 mL injection, 10 mL vial (Bavencio) |
13131D |
PEMBROLIZUMAB, pembrolizumab 100 mg/4 mL injection, 4 mL vial (Keytruda) |
Alterations
Alteration – Note
13169D | CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
13161Q | CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
Alteration – Restriction
13161Q |
CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
13169D |
CEMIPLIMAB, cemiplimab 350 mg/7 mL injection, 7 mL vial (Libtayo) |
13823M |
TEBENTAFUSP, tebentafusp 100 microgram/0.5 mL injection, 0.5 mL vial (Kimmtrak) |
Alteration – Manufacturer Code
From | To | ||
12479T | Abevmy – BEVACIZUMAB, bevacizumab 100 mg/4 mL injection, 4 mL vial | AF | SZ |
12479T | Abevmy – BEVACIZUMAB, bevacizumab 400 mg/16 mL injection, 16 mL vial | AF | SZ |
10391X | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
10401K | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
10581X | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
10588G | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
4632T | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
4639E | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
4650R | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
4703M | Ogivri – TRASTUZUMAB, trastuzumab 150 mg injection, 1 vial | AF | SZ |
Alteration – Number of Repeats
From | To | ||
13787P |
OBINUTUZUMAB, obinutuzumab 1 g/40 mL injection, 40 mL vial (Gazyva) |
5 | 7 |
Related Pharmaceutical Benefits for Public Hospital use
Additions
Addition – Brand
11103J | FOSAPREPITANT MEDSURGE, DZ – FOSAPREPITANT, fosaprepitant 150 mg injection, 1 vial |
Deletions
Deletion – Item
5987D | TROPISETRON, tropisetron 5 mg/5 mL injection, 5 mL ampoule (Tropisetron-AFT) |
Supply Only
When a product is deleted from the Schedule it may be available under Supply Only rules. Supply Only items/brands are available on the Schedule for dispensing but not for prescribing, usually for a period of up to 12 months from when it is deleted.
Substitution of Supply Only items/brands with products flagged as “equivalent for substitution” still apply as specified in the Schedule at the time the script was written.
Further information on Supply Only arrangements is available at https://www.pbs.gov.au/browse/medicine-listing/supply-only
Supply Only Commencing 1 April 2024
12673B | DARATUMUMAB, daratumumab 1.8 g/15 mL injection, 15 mL vial (Darzalex SC) |